Amylose AA
Veille bibliographique : Amylose AA
Les articles sont classés du plus ancien au plus récent, n’hésitez pas à utiliser la barre de recherche pour filtrer les résultats par date par exemple.
| Yilmaz S et al. Tocilizumab in the treatment of patients with AA amyloidosis secondary to familial Mediterranean fever Rheumatology (Oxford). 2015 Mar;54(3):564-5 | Lire le résumé |
| Hamanoue S et al. Successful treatment with humanized anti-interleukin-6 receptor antibody (tocilizumab) in a case of AA amyloidosis complicated by familial Mediterranean fever. Mod Rheumatol. 2016 Jul;26(4):610-3 | Lire le résumé |
| Lane T et al.Safety and efficacy of empirical interleukin-1 inhibition using anakinra in AA amyloidosis of uncertain aetiology. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. 2017 Sep;24(3):189–93. | Lire le résumé |
| Blank N, Hegenbart U, Dietrich S, Brune M, Beimler J, Röcken C, et al. Obesity is a significant susceptibility factor for idiopathic AA amyloidosis. Amyloid. 2018 Jan 2;25(1):37–45. | Lire le résumé |
| Esatoglu SN, Hatemi G, Ugurlu S, Gokturk A, Tascilar K, Ozdogan H. Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study. Medicine. 2017 Aug;96(34):e7859. Stankovic Stojanovic K, Georgin-Lavialle S, Poitou C, Buob D, Amselem S, Grateau G, et al. AA amyloidosis is an emerging cause of nephropathy in obese patients. European Journal of Internal Medicine. 2017 Apr;39:e18–20. | Lire le résumé Complément de résumé |
| Okuda Y,Yamada T, Ueda M, Ando Y. First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan. Internal Medicine [Internet]. 2019 [cited 2018 Oct 29]; Available from: https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_1099-18/_article | Lire le résumé |
| , Calderaro JLetouzé E, Bayard Q, Boulai A, Renault V, Deleuze J-F, et al. Systemic AA Amyloidosis Caused by Inflammatory Hepatocellular Adenoma. New England Journal of Medicine. 2018 Sep 20;379(12):1178–80. | Lire le résumé |
| Kisla Ekinci RM, Balci S, Bisgin A, Hershfield M, Atmis B, Dogruel D, et al. Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab. Pediatrics. 2018 Nov;142(5):e20180948 Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2. New England Journal of Medicine. 2014 Mar 6;370(10):911–20 Batu ED, Karadag O, Taskiran EZ, Kalyoncu U, Aksentijevich I, Alikasifoglu M, et al. A Case Series of Adenosine Deaminase 2-deficient Patients Emphasizing Treatment and Genotype-phenotype Correlations. The Journal of Rheumatology. 2015 Aug;42(8):1532–4 | Lire le résumé |
| 1. Sarıtaş H, Sendogan DO, Kumru G, Sadioglu RE, Duman N, Erturk S, et al. Long-term Results of Kidney Transplantation in Patients With Familial Mediterranean Fever and Amyloidosis. Transplant Proc [Internet]. août 2019 [cité 26 août 2019] 2. Sendogan DO, Saritas H, Kumru G, Eyupoglu S, Sadioglu RE, Tuzuner A, et al. Outcomes of Canakinumab Treatment in Recipients of Kidney Transplant With Familial Mediterranean Fever: A Case Series. Transplant Proc [Internet]. août 2019 [cité 26 août 2019] | Lire le résumé |
| Brunger AF, Nienhuis HLA, Bijzet J, Hazenberg BPC. Causes of AA amyloidosis: a systematic review. Amyloid. 2 janv 2020;27(1):1‑12. | Lire le résumé |
| Sikora J, Kmochová T, Mušálková D, Pohludka M, Přikryl P, Hartmannová H, et al. A mutation in the SAA1 promoter causes hereditary amyloid A amyloidosis. Kidney Int. sept 2021;S008525382100867X. | Lire le résumé |
| Khellaf G, Benziane A, Kaci L, Ait-Idir D, Missoum S, Benabadji M. Renal involvement in familial Mediterranean fever in an Algerian population. Clin Nephrol. 2023 Apr;99(4):172-179. doi: 10.5414/CN110930. PMID: 36734158.. (PubMed) | Lire le résumé |
| Oliveira-Silva C, Marques N, Pinho A, Poínhos R, Bergantim R, Nunes AT, Sampaio S, Rodrigues-Pereira P, Silva R, Praça A, Frazão J, Pestana M, Tavares I. Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement. Nephron. 2023;147(3-4):158-169. doi: 10.1159/000525675. Epub 2022 Sep 12. PMID: 36096123. | Lire le résumé |